A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
Abstract Efficacy of PA21 (sucroferric oxyhydroxide), a novel calcium-free polynuclear iron(III)-oxyhydroxide phosphate binder, was compared with that of sevelamer carbonate in an